Clinical Trial Update: Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update for a fixed-dose combination of an angiotensin receptor blocker and a thiazide diuretic in essential hypertension; the study is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Fixed-dose combination ARB + thiazide diuretic

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Essential Arterial Hypertension | Phase 3 | Status: NOT_YET_RECRUITING